Management Board

Chief Operating Officer at Captor Therapeutics. Ph.D. in Biochemistry from the University of Wroclaw and Executive MBA from WSB Wroclaw University. Having 20 years of R&D experience, she is responsible for day-to-day operations, overseeing the implementation of optimal processes, standards, and solutions to help the business run smoothly. In her role she has the opportunity for continuous development, and solving daily challenges gives her a lot of satisfaction. As for hobbies, she is an avid traveller and book lover.

As a Chief Technology Officer, he oversees cross-functional discovery activities within projects. He holds a Ph.D. from Charles University and completed his post-doctoral training in molecular pharmacology at the University of Glasgow. With over 25 years of experience in the industry, he has progressed from early drug discovery to clinical development while leading cross-functional teams, notably at AstraZeneca R&D and SOTIO Biotech. In his leisure time, he enjoys walking in nature and reading books.

Michał Walczak is a Chief Executive Officer, Chief Scientific Officer, responsible for R&D and strategy. He obtained a PhD degree from the Swiss Federal Institute of Technology in Zurich, ETH Zurich, and studied at the University of Wroclaw and University of Virginia. He completed his postdoctoral training at the Friedrich Miescher Institute for Biomedical Research in Basel, which is a part of Novartis Institutes for Biomedical Research.